투자판단관련주요경영사항 (인간 히알루로니다제 제품(ALTB4) 독점적 라이선스 계약 체결)[코]
Received: 1/20/2026 · Reporter: 알테오젠
A summary for this filing type is not yet available. Please refer to the original DART filing.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 32 filings
- Same category
- 23 filings
- Previous same-category filing
- 8/7/2026
- Corrections / withdrawals
- 0 filings
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).